Target Name: MIR653
NCBI ID: G724023
Review Report on MIR653 Target / Biomarker Content of Review Report on MIR653 Target / Biomarker
MIR653
Other Name(s): MicroRNA 653 | hsa-mir-653 | MIRN653 | hsa-miR-653-3p | microRNA 653 | mir-653 | hsa-miR-653-5p

MIR653: A Potential Drug Target and Biomarker for Cancer

MicroRNA 653 (MIR653) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR653 is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases.

MIR653 is a small non-coding RNA molecule that is approximately 20-22 amino acids in length. It is expressed in various tissues and cells in the body and is primarily regulated by the microRNA (miRNA) pathway. MIR653 is a negative regulator of the miRNA pathway and is shown to interact with several known miRNAs, including miR-18a, miR-202, and miR-21.

One of the unique features of MIR653 is its expression pattern. MIR653 is typically expressed in the cytoplasm of actively dividing cells and is downregulated in the cytoplasm of cells that have stopped dividing. This downregulation is regulated by the miRNA pathway and is shown to be dependent on the expression level of MIR653 itself.

MIR653 has been shown to play a role in the development and progression of various diseases, including cancer. For example, MIR653 has been shown to be downregulated in various types of cancer and has been shown to be a potential drug target for cancer treatment.

One of the potential mechanisms by which MIR653 may contribute to cancer development is its role in cell proliferation. MIR653 is shown to be a negative regulator of the miRNA pathway and is shown to inhibit the activity of several known miRNAs that are involved in cell proliferation. For example, MIR653 has been shown to interact with miR-18a, a known regulator of cell proliferation, and has been shown to inhibit the activity of miR-18a in cell proliferation.

Another potential mechanism by which MIR653 may contribute to cancer development is its role in cell migration. MIR653 has been shown to play a role in the regulation of cell migration and has been shown to interact with several known miRNAs that are involved in cell migration. For example, MIR653 has been shown to interact with miR-202, a known regulator of cell migration, and has been shown to regulate the activity of miR-202 in cell migration.

In addition to its role in cancer development, MIR653 has also been shown to have potential as a drug target or biomarker. For example, MIR653 has been shown to interact with several known drugs and has been shown to play a role in the regulation of drug response. For example, MIR653 has been shown to interact with the drug rapamycin, which is used to treat cancer and has been shown to inhibit the activity of miR-18a in cell proliferation.

MIR653 has also been shown to play a role in the regulation of stem cell maintenance. MIR653 has been shown to interact with several known miRNAs that are involved in stem cell maintenance and has been shown to regulate the activity of these miRNAs. For example, MIR653 has been shown to interact with miR-21, a known regulator of stem cell maintenance, and has been shown to regulate the activity of miR-21 in stem cell maintenance.

In conclusion, MIR653 is a small non-coding RNA molecule that has been shown to play a role in the development and progression of various diseases, including cancer. MIR653 is a key regulator of cell proliferation and has been shown to interact with several known miRNAs that are involved in cell proliferation, migration, and stem cell maintenance. As a potential drug target or biomarker, MIR653 is a promising target for cancer treatment. Further research is needed to fully understand the role of MIR653 in disease progression and to develop effective treatments for cancer.

Protein Name: MicroRNA 653

The "MIR653 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR653 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792